Genes involved in hemorrhagic transformations that follow recombinant t-PA treatment in stroke patients

Pharmacogenomics

Volumn 14, Issue 5, 2013, Pages 495-504

  Fernandez Cadenas, Israel ^a,b   Rio Espinola, Alberto Del ^a,b   Domingues Montanari, Sophie ^a   Mendioroz, Maite ^a   Fernandez Morales, Jessica ^a   Penalba, Anna ^a   Rubiera, Marta ^a   Hernandez Guillamon, Mar ^a   Rosell, Anna ^a   Delgado, Pilar ^a   Chacon, Pilar ^a   Ribo, Marc ^a   Alvarez Sabin, Jose ^a   Molina, Carlos A ^a   García Arumi, Elena ^a   Montaner, Joan ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Fundació Docència i Recerca MútuaTerrassa ^*  (Spain)

Author keywords

hemorrhagic transformation; microarrays; rt PA; stroke; transcription

Indexed keywords

ALTEPLASE; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 8; CYSTEINE RICH SECRETORY PROTEIN 3; G PROTEIN COUPLED RECEPTOR 84; LACTOFERRIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OLFACTOMEDIN 4 PROTEIN; PROTEIN BCL 2; RNA; UNCLASSIFIED DRUG;

AGED; APOPTOSIS; ARTICLE; BCL2 GENE; BLEEDING DISORDER; BLOOD SAMPLING; BRAIN HEMORRHAGE; CEACAM8 GENE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRISP3 GENE; DRUG SAFETY; FEMALE; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEMORRHAGIC TRANSFORMATION; HUMAN; LCN2 GENE; LTF GENE; MALE; MICROARRAY ANALYSIS; NEUTROPHIL; OLFM4 GENE; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA REPLICATION; TRANSCRIPTOMICS;

APOPTOSIS; DRUG TOXICITY; FEMALE; GENE REGULATORY NETWORKS; HEMORRHAGE; HUMANS; MALE; NEUTROPHILS; RECOMBINANT PROTEINS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84875962014     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.19     Document Type: Article

References (39)

1. Wahlgren N, Ahmed N, Davalos A et al SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369, 275-282 (2007 (Pubitemid 46138121)
2. Hacke W, Kaste M, Bluhmki E et al. ECASS Investigators: thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329 (2008
3. Lichtman JH, Watanabe E, Allen NB, Jones SB, Dostal J, Goldstein LB. Hospital arrival time and intravenous t-PA use in US academic medical centers, 2001-2004. Stroke 40, 3845-3850 (2009
4. Castellanos M, Leira R, Serena J et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 34, 40-46 (2003
5. Castellanos M, Leira R, Serena J et al. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35, 1671-1676 (2004 (Pubitemid 38823645)
6. Hernandez-Guillamon M, Garcia-Bonilla L, Sole M et al. Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke 41, 1528-1535 (2010
7. Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39, 1121-1126 (2008 (Pubitemid 351440679)
8. Cuadrado E, Ortega L, Hernandez-Guillamon M et al. Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release. J. Leukoc. Biol. 84, 207-214 (2008 (Pubitemid 351960296)
9. Jickling GC, Xu H, Stamova B et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann. Neurol. 68, 681-692 (2010
10. Tang Y, Xu H, Du X et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J. Cereb. Blood Flow Metab. 26, 1089-1102 (2006 (Pubitemid 44134079)
11. Barr TL, Conley Y, Ding J et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology 75, 1009-1014 (2012
12. Brott TG, Haley EC, Levy DE et al. Urgent therapy for stroke, part I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23, 632-640 (1992
13. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 274, 1017-1025 (1995
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003
15. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article 3 (2004
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc. B. 57, 289-300 (1995
17. Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S. Bioinformatics and Computational Biology Solutions using R and Bioconductor. Gentleman R (Ed). Springer, NY, USA (2005
18. Rosell A, Vilalta A, García-Berrocoso T et al. Brain perihematoma genomic profile following spontaneous human intracerebral hemorrhage. PLoS ONE 6, e16750 (2011
19. Calvano SE, Xiao W, Richards DR et al. A network-based analysis of systemic inflammation in humans. Nature 437, 1032-1037 (2005 (Pubitemid 41486985)
20. Kitagawa K. CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J. 274, 3210-3217 (2007 (Pubitemid 47024985)
21. Mattson MP. Calcium and neurodegeneration. Aging Cell 6, 337-350 (2007
22. Kobayashi D, Koshida S, Moriai R, Tsuji N, Watanabe N. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Cancer Sci. 98, 334-340 (2007 (Pubitemid 46195603)
23. Parsey MV, Kaneko D, Shenkar R, Abraham E. Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1b. Chest 116(Suppl. 1), S67-S68 (1999
24. Mercer-Jones MA, Heinzelmann M, Peyton JC, Wickel D, Cook M, Cheadle WG. Inhibition of neutrophil migration at the site of infection increases remote organ neutrophil sequestration and injury. Shock 8, 193-199 (1997 (Pubitemid 127654326)
25. Ueta E, Tanida T, Osaki T. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J. Pept. Res. 57, 240-249 (2001 (Pubitemid 32232067)
26. Sorimachi K, Akimoto K, Hattori Y, Ieiri T, Niwa A. Activation of macrophages by lactoferrin: secretion of TNF-a, IL-8 and NO. Biochem. Mol. Biol. Int. 43, 79-87 (1997 (Pubitemid 28297194)
27. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatenase. J. Biol. Chem. 268, 10425-10432 (1993 (Pubitemid 23150227)
28. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human lipocalin. Scand. J. Clin. Lab. Invest. 55, 577-588 (1995
29. Kuijpers TW, van der Schoot CE, Hoogerwerf M, Roos D. Cross-linking of the carcinoembryonic antigen-like glycoproteins CD66 and CD67 induces neutrophil aggregation. J. Immunol. 151, 4934-7940 (1993
30. Skubitz KM, Campbell KD, Skubitz AP. CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J. Leukoc. Biol. 60, 106-117 (1996 (Pubitemid 26248889)
31. Smolen J, Boxer L. Functions of neutrophils. In: Williams Hematology (6th Edition). McGraw-Hill Professional, NY, USA, 761-784.
32. Pak V, Budikhina A, Pashenkov M, Pinegin B. Neutrophil activity in chronic granulomatous disease. Adv. Exp. Med. Biol. 601, 69-74 (2007
33. Udby L, Calafat J, Sørensen OE, Borregaard N, Kjeldsen L. Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils. J. Leukoc. Biol . 72, 462-469 (2002
34. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258-37265 (2001
35. Fernandez-Cadenas I, Del Río-Espínola A, Carrera C et al. Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients. Stroke 43(5), 1398-1400 (2012
36. Hernandez-Guillamon M, Sole M, Delgado P et al. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic. Stroke Cerebrovasc. Dis. 33(1), 55-63 (2012
37. Del Río-Espínola A, Fernandez-Cadenas I, Giralt D et al. A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke. Ann. Neurol. 72(5), 716-729 (2012
38. Open source software for bioinformatics. www.bioconductor.org
39. Ingenuity Systems: pathway analysis, mRNA, RNA sequencing, NGS and microarray. www.ingenuity.com